| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $446K | — | -93.7% |
| Cost of Revenue | $193K | — | -94.7% |
| Gross Profit | $253K | — | -92.7% |
| R&D Expense | $965K | — | -85.2% |
| SG&A Expense | $2.2M | — | -52.4% |
| Operating Income | -$4.9M | — | +39.4% |
| Pre-tax Income | -$4.6M | — | +42.5% |
| Income Tax | -$22K | — | -164.7% |
| Net Income | $80.6M | — | +1138.3% |
| EPS (Basic) | $12.69 | — | +9861.5% |
| EPS (Diluted) | $12.46 | — | +9684.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $57.8M | +414.3% | +212.5% |
| Current Assets | $59.2M | +17.8% | +93.4% |
| Total Assets | $60.0M | +17.0% | +2.6% |
| Current Liabilities | $2.1M | -89.5% | -76.3% |
| Total Liabilities | $2.8M | -86.7% | -88.4% |
| Stockholders' Equity | $57.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.6M | — | +31.8% |
| Capital Expenditures | $105K | — | +517.6% |
| Investing Cash Flow | $44.3M | — | — |
| Financing Cash Flow | $5K | — | -99.7% |
| Free Cash Flow | -$4.7M | — | +30.4% |
| +458.2% |